APA (7th ed.) Citation

Leclercq, M., Goupillou, P., Gomez, H., Muraine, M., Benhamou, Y., Girszyn, N., & Gueudry, J. (2023). Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis. Journal of Ophthalmic Inflammation & Infection, 13(1), 1. https://doi.org/10.1186/s12348-023-00336-3

Chicago Style (17th ed.) Citation

Leclercq, Mathilde, Paul Goupillou, Hélène Gomez, Marc Muraine, Ygal Benhamou, Nicolas Girszyn, and Julie Gueudry. "Efficacious Switching from Subcutaneous to Intravenous Tocilizumab in Patients with Non-infectious Non-anterior Uveitis." Journal of Ophthalmic Inflammation & Infection 13, no. 1 (2023): 1. https://doi.org/10.1186/s12348-023-00336-3.

MLA (9th ed.) Citation

Leclercq, Mathilde, et al. "Efficacious Switching from Subcutaneous to Intravenous Tocilizumab in Patients with Non-infectious Non-anterior Uveitis." Journal of Ophthalmic Inflammation & Infection, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1186/s12348-023-00336-3.